# Endostar Combined With Intensity-modulated Radiotherapy Compare With Chemoradiation for Nasopharyngeal Carcinoma

> **NCT02237924** · PHASE2 · COMPLETED · sponsor: **First Affiliated Hospital of Guangxi Medical University** · enrollment: 120 (actual)

## Conditions studied

- Nasopharyngeal Carcinoma

## Interventions

- **DRUG:** endostar
- **DRUG:** DDP
- **RADIATION:** IMRT

## Key facts

- **NCT ID:** NCT02237924
- **Lead sponsor:** First Affiliated Hospital of Guangxi Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-09
- **Primary completion:** 2021-09
- **Final completion:** 2022-01
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2022-02-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02237924

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02237924, "Endostar Combined With Intensity-modulated Radiotherapy Compare With Chemoradiation for Nasopharyngeal Carcinoma". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02237924. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*